|
|
|
Audit
Repository Center (ARC)
|
Click
here to visit the Audit Repository Center.
Click
here to purchase PDA Technical Report No. 32
from the PDA Bookstore.
Brief History of ARC and PDA Technical Report
No. 32:
Companies
who supply computer products and services (suppliers)
to pharmaceutical companies (manufacturers) are
required, by regulation or good business practices,
to audit their performance. PDA Technical Report
No. 32: Auditing of Suppliers Providing Computer
Products and Services for Regulated Pharmaceutical
Operations (TR-32) defines a six-step process
for performing such an audit. Each of the steps
represents a collection of activities to be accomplished
by qualified auditors, manufacturers, and suppliers.
TR-32
followed in the aftermath of the U.S.
Food and Drug Administration's (FDA's) appeal
to the regulated industry to standardize the auditing
process for suppliers of computer products and
services and establish a global repository for
sharing audit information. The issues that concerned
FDA included:
|
-
Uncertainty: Without an objective standard for
all suppliers to follow, the obvious dilemma
is that a supplier can never be reasonably certain
that they are in compliance.
-
Inconsistency: Unless the objective standard
is applied uniformly, from company to company,
it is fair to say that all companies are not
being treated alike. Some companies are more
in compliance, while others are less compliant.
-
Redundancy: Because a supplier is often requested
to submit to audits by a number of client manufacturers,
a global repository makes sense since it would
avoid a duplicative process.
-
Cost: Survey data at the time suggested that
the beginning to close-out cost, per audit,
was approximately $8,000 to $10,000 each to
the manufacturer and the supplier. A global
repository would reduce spiraling costs since
suppliers are often audited several times in
one year.
|
|
As
a result of FDA's concerns, PDA issued TR-32 in
January of 2000 to serve as a model for suppliers
providing computer products and services for regulated
pharmaceutical operations. The following year
PDA licensed The Audit Repository Center (ARC)
to serve as the global repository for all of its
audits. ARC stores, then makes available via the
Internet, the various audits submitted by suppliers.
This allows manufacturing companies (subscribers)
or participating suppliers to obtain easy access
to the data.
To
learn more about the Audit Repository Center,
or, to subscribe to the growing number of audits
available in ARC's Repository, visit www.auditcenter.com.
|
|
|
|
|
|